SUMMER CANTRELL: Open Payments
NPI 1467917047 · SALUDA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 31 payments from 9 companies in 2025. Trend: 2023 $842 · 2024 $643 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $166 |
| Novo Nordisk Inc | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Corcept Therapeutics | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $43 |
| Exact Sciences Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: Kerendia, Ozempic, AIRSUPRA, Korlym, XIFAXAN, The Cologuard Plus Collection Kit, KISUNLA, SHINGRIX.
Industry payments across SC — which companies pay providers there.
